Results 71 to 80 of about 12,963 (197)

SBRT in operable early stage lung cancer patients.

open access: yes, 2014
Since decades the gold standard for treatment of early stage non-small cell lung cancer (NSCLC) is surgical lobectomy plus mediastinal lymph node dissection. Patients in worse health status are treated with sublobar resection or radiation treatment. With
Andratschke N, Roesch J, Guckenberger M
core   +1 more source

MRI-guided lung SBRT: Present and future developments [PDF]

open access: yes, 2017
Stereotactic body radiotherapy (SBRT) is rapidly becoming an alternative to surgery for the treatment of early-stage non-small cell lung cancer patients.
Wetscherek, A   +8 more
core   +1 more source

A dose‐escalated radiation protocol of 10 × 4.0 Gy provides long‐term local control in canine apocrine gland anal sac adenocarcinoma

open access: yesJournal of Small Animal Practice, EarlyView.
Objectives To obtain insights for establishing radiation therapy strategies that provide long‐term locoregional benefits in canine apocrine gland anal sac adenocarcinoma, we evaluated whether a dose‐escalated protocol (10 × 4.0 Gy) could improve clinical outcomes, particularly long‐term locoregional control, while maintaining acceptable toxicity ...
M. Terauchi   +3 more
wiley   +1 more source

IMRT, IGRT, SBRT - Advances in the Treatment Planning and Delivery of Radiotherapy

open access: yes, 2011
Over the last 4 years, IMRT, IGRT, SBRT: Advances in the Treatment Planning and Delivery of Radiotherapy has become a standard reference in the field.
Meyer, J. L., Meyer, J.L.
core  

Comparison of Wiltse Approach‐Based Invasion‐Controlled Surgery With Traditional Open Surgery for Thoracolumbar Spinal Metastases Within the NOMS Framework

open access: yesOrthopaedic Surgery, EarlyView.
Invasion‐controlled surgery via the Wiltse approach for thoracolumbar spine metastasis significantly reduces blood loss, shortens operation time, and accelerates postoperative radiotherapy, while maintaining neurological outcomes—optimizing tumor control under the NOMS framework.
Pengru Wang   +7 more
wiley   +1 more source

Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectives

open access: yes, 2018
Elysia K Donovan,1,2 Anand Swaminath1,2 1Department of Oncology, McMaster University, Hamilton, ON, Canada; 2Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada Abstract: Stereotactic body radiation therapy (SBRT) has emerged as a
Donovan EK, Swaminath A
core  

Assessment of simulated respiratory gating based on external‐to‐internal motion prediction using a hybrid, adaptive deep‐learning network

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 12, December 2026.
Abstract Purpose To assess the accuracy, safety, and efficiency of respiratory‐gated radiotherapy (RGRT) based on internal respiratory waveforms predicted by a hybrid long short‐term memory (LSTM) deep‐learning network, which adapts to breathing irregularities through the application of time‐domain cross‐correlation (TCC) to check and correct any ...
Andrew Milewski, Xingyu Nie, Guang Li
wiley   +1 more source

Normal tissue tolerance for HCC SBRT in 3 fractions.

open access: yes, 2016
Normal tissue tolerance for HCC SBRT in 3 fractions.
Jungwon Kwak (3358880)   +6 more
core   +1 more source

Radiation‐Induced Skin Injury in Cancer Radiotherapy: From Mechanisms to Management

open access: yesAdvanced Oncology, Volume 1, Issue 1, December 2026.
Radiation‐induced skin injuries (RISI) remain a significant challenge faced by cancer patients receiving radiotherapy (RT). This perspective article examines the pathophysiology of RISI and evaluates the currently existing and emerging therapeutic strategies, including stem cell‐derived exosomes and advanced hydrogels.
Zeynep Meral Toutoungi   +3 more
wiley   +1 more source

Lung SBRT through Radiobiology

open access: yes, 2020
Purpose: Stereotactic body radiation therapy (SBRT) has emerged as a standard treatment modality for medically inoperable early-stage lung cancer patients.
Aime M Gloi
core  

Home - About - Disclaimer - Privacy